Dairy bacteria could treat inflammatory bowel disease

LONDON, September 1 (SPIS MedWire). A new treatment for inflammatory bowel disease (IBD) has been developed involving a bacterium used in the manufacture of dairy products. Scientists at the Flanders Interuniversity Institute for Biotechnology genetically modified Lactococcus lactis to produce anti-inflammatory interleukin-10 (IL-10). Administered orally in mice, the strain appeared to prevent and even cure chronic IBD. Conventional treatments administered orally or by injection are hindered bec

By | September 1, 2000

LONDON, September 1 (SPIS MedWire). A new treatment for inflammatory bowel disease (IBD) has been developed involving a bacterium used in the manufacture of dairy products. Scientists at the Flanders Interuniversity Institute for Biotechnology genetically modified Lactococcus lactis to produce anti-inflammatory interleukin-10 (IL-10). Administered orally in mice, the strain appeared to prevent and even cure chronic IBD. Conventional treatments administered orally or by injection are hindered because only small amounts of medicine actually reach the target site, and side-effects occur because large amounts enter healthy tissues. Using Lactococcus lactis to produce IL-10 overcomes these problems because the IL-10 is delivered locally to the intestine. This also prevents IL-10 being degraded in the stomach and small intestine, so 10,000 times less IL-10 is needed to possibly cure IBD.

Popular Now

  1. Major German Universities Cancel Elsevier Contracts
  2. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  3. Most of Human Genome Nonfunctional: Study
  4. Identifying Predatory Publishers
AAAS